HCA Healthcare: Soft-Season Selloff Looks Overdone — Buy the Pullback
HCA plunged after flagging a weak respiratory season, but the balance sheet, cash flow, and valuation argue the market has priced in most of the downside. We upgrade to a tactical long: entry $367, stop $345, target $400 over a mid-term 45 trading day horizon.